Carolyn I. Rodriguez, MD, PhD

JCP
Brief Report

June 30, 2020

This case series investigates the potential for nitrous oxide to rapidly reduce symptoms of posttraumatic stress disorder. Did it help the 3 Veteran outpatients who received it? Read this...
Andrea Varias, Peter van Roessel, Maryam Parsiani, et al
JCP
Letter to the Editor

February 21, 2018

Read a study investigating the effects of rapastinel administration on 7 patients with OCD.
Omer Linkovski, Hanyang Shen, Jordana Zwerling, et al
JCP
Letter to the Editor

April 26, 2017

Reports have indicated that a single intravenous ketamine dose rapidly decreases OCD symptoms. These researchers planned a study of nasal ketamine administration for this purpose, but they quickly encountered...
Carolyn I. Rodriguez, Kyle A. B. Lapidus, Jordana Zwerling, et al
JCP
Letter to the Editor

May 25, 2016

Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.
Carolyn I. Rodriguez, Amanda Levinson, Jordana Zwerling, et al
JCP
Letter to the Editor

March 23, 2016

Carolyn I. Rodriguez, Michael Wheaton, Jordana Zwerling, et al
JCP
Original Research

April 22, 2015

Edna B. Foa, Helen Blair Simpson, David Rosenfield, et al
JCP
Letter to the Editor

April 15, 2011

Carolyn I. Rodriguez, Lawrence S. Kegeles, Pamela Flood, et al
JCP
Letter to the Editor

September 15, 2010

Carolyn I. Rodriguez, James Bender Jr, Sue M. Marcus, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe